ComplianceOnline

Understanding and Preparing for System Based Inspections: Facilities and Equipment System

Instructor: Robert Ferer
Product ID: 701332
Training Level: Intermediate
  • Duration: 90 Min

recorded version

$149.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

$175.00
$350.00 (50%)
Save $175.00
One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This FDA Inspection training will provide you an understanding of how the FDA conducts systems based inspections, and will review examples of FDA 483 observations, so you can better prepare for your PAI.

Why should you Attend:
Development and launch of a new drug product is a time consuming and expensive undertaking. Countless man-hours and multiple millions of dollars are invested in design, construction, equipment, commissioning, validation, and testing. To protect your investment, preparation for the Pre-Approval Inspection (PAI) must be a key part of any drug launch strategy. This webinar will provide you an understanding of how the FDA conducts systems based inspections, and will review examples of FDA 483 observations, so you can better prepare for your PAI.

This system includes the measures and activities which provide an appropriate physical environment and resources used in the production of the drugs or drug products. It includes:

  • Buildings and facilities along with maintenance;
  • Equipment qualifications (installation and operation); equipment calibration and preventative maintenance; and cleaning and validation of cleaning processes as appropriate.
  • Utilities that are not intended to be incorporated into the product such as HVAC, compressed gases, steam and water systems.

A primary mission of the FDA is to conduct comprehensive regulatory inspections covering all aspects of production and distribution of drugs for sale in the US. Due to the ever increasing number of drug applications as well as manufacturers that wish to sell their products in the US, the FDA inspection resources were stretched too thin to ensure appropriate inspections on a biennial basis (every two years) as required. In 2001 a pilot program was launched to change the focus from profile classes (types of drugs produced) to a systems based inspection. The expectation being that the various systems covered multiple profile classes, and this would speed up the review process while ensuring compliance.

Areas Covered in the seminar:

  • Review of the Systems Based Inspection Program.
  • Preparation prior to a PAI inspection.
  • How to manage a regulatory inspection.
  • How to respond to regulatory inspection observations.
  • Review of the elements of the Facilities and Equipment System covered during the webinar.
  • Examples of what the inspection will address during the review of the Facilities and Equipment System covered during the webinar.
  • Case studies for observations found on the Facilities and Equipment System covered during the webinar.

Who will benefit:

This series of webinars will be useful to employees and management who are involved in the preparations for Pre-Approval Inspections including validation, quality, regulatory, documentation control, and operations staff

Instructor Profile:
Robert Ferer, is President and founder of The Ferer Group Inc. A graduate of the State University of New York at Stony Brook, Bob is an engineering chemist and has more than 19 years direct industry experience including the design, build, start-up, and management of facilities, specializing in aseptic manufacturing. His expertise ranges from developing and executing project master plans, schedules, and budgets to performing hands-on validation, design review, and equipment start up and commissioning. A natural leader and mentor, he presents courses as well as contributes to industry publications.

To further develop his awareness of the pharmaceutical and biotechnology industries’ advancements, Bob is an active member of the International Society of Pharmaceutical Engineers and the Parenteral Drug Association. Bob frequently managed large projects and was instrumental in providing high-level consultation to clients. This included due diligence, facility audits, PAT implementations, and technology transfer. In his role as a leader, Bob recruited, trained and developed his staff to maintain the required expertise to support the industry.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
ComplianceOnline Medical Device Summit 2017

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading